In detail, this new financing was led by Sofinnova Partners and co-managed by Intermediate Capital Group, but the transaction also benefited from the participation of historical...
Johnson & Johnson increased its sales by 1.3% in 2022, up to $95 billion, but reduces profits. Sales in the U.S. rose 2.9% to $12.5 billion...
Doctomatic was created a little over a year ago with the objective of offering a digital platform for the remote management and control of chronic patients....
Aurelian Biotech has patented its new product Biaurelian. The concept of 'biohacking', as explained by Aurelian Biotech, comes from the words 'biology' and 'hacking', and is...
Wivi Vision, which began operating in the Spanish market in December 2019, is undergoing an expansion process throughout the European Union (EU) and is already present...
With this round, most of the company's capital falls into the hands of the founding team, which controls 70%, while the remaining 30% is distributed among...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
Onalabs, a biotechnological start-up specializing in digital devices for chronic patients, has created a subsidiary in Andorra. Through two pilot programs in the principality, the Ona...
Moderna has made the announcement of new vaccines with its mRNA technology. In addition to Covid-19, the company is working with Merck on a skin cancer vaccine...
The help of EIC Accelerator will allow Gate2Brain to boost its proprietary technology based on peptides (small proteins) that cross biological barriers and reach the brain....